Accelevir develops and deploys ultrasensitive molecular assays for detecting viral load and measuring latent reservoir size in low-copy-number scenarios.
- Single-Copy Detection – Digital PCR-based workflows achieving detection limits below 1 copy/mL plasma.
- Latent Reservoir Quantification – Including quantitative viral outgrowth assay (QVOA) and intact proviral DNA assay (IPDA) for HIV.
- Cross-Platform Validation – qPCR, ddPCR, and NGS confirmation for assay accuracy and reproducibility.